Filing Flows › Longevity Health Holdings (XAGE) › Q1 2026
Longevity Health Holdings (XAGE) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 15, 2026
Longevity Health Holdings (XAGE) reported revenue of $392K for the first quarter 2026 (Q1 2026), -23% from a year earlier and -17% from the quarter before. Operating margin was -339.1%, net loss $1.4M (365.5% of revenue).
Longevity Health Holdings, Q1 2026: revenue $392K (-23% year over year), operating margin -339.1%, net loss $1.4M, operating cash flow −$485K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $392K | -17% | -23% |
| Operating profit | −$1.3M | — | — |
| Net earnings | −$1.4M | — | — |
| Operating cash flow | −$485K | — | — |
What changed
Revenue was $392K in Q1 2026, down 23% year over year and down 17% from the previous quarter.
Gross margin was 60.5%, up 7.6 points from Q1 2025. Operating costs exceeded revenue by $1.3M, an operating margin of -339.1%. Operating expenses fell 12% while revenue fell 23%. The quarter ended with a net loss of $1.4M, narrower than the previous quarter's $2.1M loss.
Operating cash flow was −$485K. Non-cash charges added back $15K of depreciation and amortization and $146K of share-based compensation. Working capital and other items added $785K.
Questions
What was Longevity Health Holdings' revenue in the first quarter 2026?
Longevity Health Holdings (XAGE) reported revenue of $392K for the first quarter 2026 (Q1 2026), -23% from a year earlier and -17% from the quarter before.
Was Longevity Health Holdings profitable in the first quarter 2026?
Operating loss was $1.3M (-339.1% of revenue) and net loss $1.4M.